Our observations are in accordance with several studies showing that BRAF mutations are related to poor prognosis in metastatic colon cancer [38], and that disease-free survival is longer in patients with colon cancer harboring abundant γδ T-cell infiltrates [39], suggesting a beneficial anti-tumor role of γδ T-cells. This evidence concerns the gene BRAF and malignant colon neoplasm.